IMAC Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BACK research report →
Price Chart
About the company
IMAC Holdings, Inc. operates a network of advanced medical and regenerative care facilities across the United States. Through its outpatient clinics, the company delivers a range of regenerative, orthopedic, and minimally invasive treatments.
- CEO
- Faith Zaslavsky
- IPO
- 2019
- Employees
- 15
- HQ
- Franklin, TN, US
Get TickerSpark's AI analysis on BACK
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.89K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.08
- P/B
- -0.00
- EV/EBITDA
- -0.57
- Div Yield
- 0.00%
- Gross Margin
- -1349.60%
- Op Margin
- -26468.83%
- Net Margin
- -32560.25%
- ROE
- 72.93%
- ROIC
- 65.74%
Latest fiscal year · YoY change
- Revenue
- $72.05K-98.6%
- Gross Profit
- $-233,198-106.1%
- Op Income
- $-5,623,267
- Net Income
- $-9,045,827+4.0%
- EPS
- $-7.76-33.3%
- OCF Growth
- -13.3%
- FCF Growth
- -13.3%
- 52W High
- $0.21
- 52W Low
- $0.00
- 50D MA
- $0.02
- 200D MA
- $0.06
- Beta
- 1.78
- RSI (14)
- 18
- Avg Volume
- 14.14K
No earnings-call transcripts are available for BACK yet.
- Free Float
- 98.4%
- Shares Outstanding
- 3.78M
- Float Shares
- 3.72M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 31, 23 | Ruiz Jorge | other | 0 |
| Apr 5, 24 | Ruiz Jorge | buy | 1 |
| Mar 27, 24 | Ruiz Jorge | sell | 5,000 |
| Mar 25, 24 | Ruiz Jorge | sell | 100 |
| Mar 25, 24 | Ruiz Jorge | sell | 200 |
| Mar 25, 24 | Ruiz Jorge | sell | 500 |
| Mar 25, 24 | Ruiz Jorge | sell | 1,000 |
| Mar 25, 24 | Ruiz Jorge | sell | 356 |
| Mar 22, 24 | Ruiz Jorge | buy | 164,872 |
| Mar 22, 24 | Ruiz Jorge | sell | 16,487 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BACK coverage
Recent articles, reports, and earnings notes.
No research on BACK yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BACK report →Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers
globenewswire.com · Sep 10
Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference
globenewswire.com · Feb 24
Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay
globenewswire.com · Feb 19
Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response
globenewswire.com · Feb 10
IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies
globenewswire.com · Jan 27
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
globenewswire.com · Nov 22
IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1)
globenewswire.com · Nov 14
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
globenewswire.com · Sep 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.